UBS Group’s Rennova Health, Inc. Warrant RNVAZ Stock Holding History

UBS Group’s Portfolio RNVAZ Stock Details RNVAZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-24,561	Closed	–	–	8413
2017 Q3	$0	Sell	24,561 -4,980	-17%	-$141	﹤0.01%	8271
2017 Q2	$2K	Buy	29,541 +8,765	+42%	+$169	﹤0.01%	7448
2017 Q1	$0	Sell	20,776 -9,324	-31%	-$251	﹤0.01%	8302
2016 Q4	$1K	Buy	+30,100	New	+$1.18K	﹤0.01%	7701

UBS Group's RNVAZ Position: Q4 2017 in Review

UBS Group sold out of Rennova Health, Inc. Warrant (RNVAZ) in Q4 2017, closing a stake of 24,561 shares.

UBS Group first reported a position in RNVAZ in Q4 2016 and held it in 4 quarters. The position peaked at $2K in Q2 2017. 0 funds tracked by Wall St. Rank hold RNVAZ as of Q4 2017.

UBS Group reported no remaining Rennova Health, Inc. Warrant position as of Q4 2017 after selling out during the quarter.
UBS Group sold 24,561 Rennova Health, Inc. Warrant shares in Q4 2017.
UBS Group first reported a position in Rennova Health, Inc. Warrant in Q4 2016 and held it in 4 quarters.
UBS Group's Rennova Health, Inc. Warrant position peaked at $2K in Q2 2017.
0 funds tracked by Wall St. Rank held Rennova Health, Inc. Warrant as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.